Buy Arjuna 60 caps
Worldwide: $ 9.95 X  Nos

The bark is useful as an anti-ischemic and cardioprotective agent in hypertension and in ischemic heart disease. It also has a tonic effect in cases of cirrhosis of the liver. It induces a drug-dependent decrease in blood pressure and heart rate. It has been reported to possess protective cardiovascular and hypolipidemic properties.

It reduces the level of triglycerides and cholesterol and has been reported to enhance the synthesis of LDL-apoprotein (apoB). It inhibits the oxidation of LDL and accelerates the turnover of LDL-cholesterol in liver. This enhances the elimination of cholesterol from the body. The suppression of hepatic cholesterol biosynthesis by Terminalia arjuna is the mechanism responsible for a significant lowering of beta-lipoprotein lipids and the recovery of HDL components in hyperlipidemia.

In a study on the efficacy of the bark powder in treating congestive cardiac failure (CCF), over 40% of the cases showed marked improvement. CCF due to congenital anomaly of heart and valve disease was also brought under control. 4 out of 9 cases of CCF due to chronic bronchitis were also relieved by the treatment. Arjuna relieved symptomatic complaints of essential hypertension viz. giddiness, insomnia, lassitude, headache and the inability to concentrate. Oral administration of an aqueous suspension of the bark powder reduces coagulation, bleeding and prothrombin time.

Dosage*
1 capsule 2 times a day before meals.
* Recommended for 8 years and above.